Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03012958 · ClinicalTrials.gov registry record
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
A clinical trial of Dyspnea and Bronchiolitis, sponsored by National Jewish Health.
- Completed
- Registry status
- 73
- Enrollment target
- 1
- Study location
NCT03012958: Completed study of Dyspnea and Bronchiolitis, sponsored by National Jewish Health.
NCT03012958 is a study of Dyspnea and Bronchiolitis that has completed, run by National Jewish Health. The registered enrollment target is 73 participants, below the 302-participant average among 23 other Dyspnea trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03012958, a study of Dyspnea and Bronchiolitis, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about new noninvasive ways of detecting lung disease in US Military personnel and people who worked as contractors during military operations in Iraq and Afghanistan. This study is looking at conducting a type of breathing test called the lung clearance index (LCI) test which is being investigated as a potential noninvasive way to detect the type of lung disease that may be seen in symptomatic deployers retuning from Iraq and Afghanistan.
Primary Outcome
Average of three acceptable trials
Conditions Studied
Interventions
- OTHER Lung clearance index (LCI)
Study Locations (1)
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-05 |
What the finished NCT03012958 record still lists
NCT03012958 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 302-participant average among 23 other Dyspnea trials with a reported enrollment target (76% lower).
The record links to 3 conditions, with Dyspnea appearing as the primary indexed condition, and to 1 intervention - of which Lung clearance index (LCI) is the first listed.
NCT03012958 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03012958 about?
NCT03012958 is a clinical study titled "Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease". The purpose of this study is to learn more about new noninvasive ways of detecting lung disease in US Military personnel and people who worked as contractors during military operations in Iraq and Afghanistan. This study is looking at conducting a type of breathing test called the lung clearance ind...
What is the current status of trial NCT03012958?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2014-07. Estimated completion is 2018-05.
What conditions does trial NCT03012958 study?
This clinical trial studies the following conditions: Dyspnea, Bronchiolitis, Pneumonitis.
What interventions are being tested in trial NCT03012958?
The interventions under investigation include: Lung clearance index (LCI) (OTHER).
Who is sponsoring clinical trial NCT03012958?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03012958 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03012958's enrollment target sits among peer trials
73 12th of 23 higher than 12 of 23 other Dyspnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyspnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
RECRUITING · Phase 2
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
RECRUITING
-
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RECRUITING · Phase 2
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia